HomeTagsNMPA Approval

NMPA Approval

Biotechnology

CStone and Pfizer Announce NMPA Approval of Sugemalimab in Patients With Unresectable Stage Iii Non-small Cell Lung Cancer

PR Newswire - June 6, 2022

CStone Pharmaceuticals, a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Pfizer Inc. announced that...

Biotechnology

Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG

PR Newswire - March 28, 2022

Shanghai Henlius Biotech, Inc. announced that its first self-developed innovative PD-1 inhibitor HANSIZHUANG has been approved by the National Medical Products Administration (NMPA) for...